Brief: Microport Neurotech Says Tigertriever Recently Approved For Commercialization
18/08/2023 15:29
Aug 18 (Reuters) - MicroPort NeuroTech Ltd 2172.HK :
* TIGERTRIEVER REVASCULARIZATION DEVICE HAS RECENTLY BEEN
APPROVED
FOR COMMERCIALIZATION BY NMPA
Further company coverage: 2172.HK
((reuters.briefs@thomsonreuters.com;))
Recent news on MicroPort NeuroScientific
See all newsBrief: MicroPort NeuroScientific Corp Says Artemis Dream Enters NMPA Green Path
Brief: Microport Neuroscientific To Continue Share Repurchases Up To Hkd100 Million
Brief: Microport Neuroscientific Says FDA Approves Numentm Helia Coil For Marketing
Brief: Microport Neuroscientific Posts FY Profit Attributable Rmb184.5 Million
Brief: Microport Neuroscientific Says FDA Grants Breakthrough Device Designation To Apollo Dream Rapamycin Stent System